mGluR5 Ligand, CDPPB
CAS: 781652-57-1
Ref. 3D-GGB65257
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
- 3-Cyano-N-(2,5-diphenyl-2H-pyrazol-3-yl)-benzamide
- 3-Cyano-N-(2,5-diphenylpyrazol-3-yl)benzamide
- Benzamide, 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)-
- Cdppb
CDPPB is a potent, selective, and orally active mGluR5 ligand. It has been shown to inhibit the activation of cell signaling pathways that are involved in dopamine release and glutamate-mediated synaptic transmission. CDPPB is characterized by allosteric activity, which means that it binds to the metabotropic glutamate receptor (mGluR) and alters its function. This drug also inhibits protein synthesis and increases locomotor activity in mice. CDPPB has been studied as a possible treatment for skin cancer and may have therapeutic potential for other diseases of the central nervous system such as Parkinson's disease.
Propiedades químicas
Consulta técnica sobre: 3D-GGB65257 mGluR5 Ligand, CDPPB
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
